SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-269392
Filing Date
2020-10-14
Accepted
2020-10-14 16:58:54
Documents
12
Period of Report
2020-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d85334d8k.htm   iXBRL 8-K 26944
  Complete submission text file 0001193125-20-269392.txt   153991

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20201009.xsd EX-101.SCH 3095
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20201009_lab.xml EX-101.LAB 18909
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20201009_pre.xml EX-101.PRE 11880
5 EXTRACTED XBRL INSTANCE DOCUMENT d85334d8k_htm.xml XML 3474
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 201239507
SIC: 2834 Pharmaceutical Preparations